Reported about 15 hours ago
Investors are encouraged to consider two ultra-high-yield dividend stocks, Pfizer and Realty Income, as ideal buys this February. Pfizer boasts a 6.49% yield driven by its successful COVID-19 products and a strong drug portfolio, despite a recent stock decline. Realty Income, with a 5.8% yield, has a consistent history of dividend payments and a resilient commercial real estate portfolio, particularly as interest rates are expected to decline. Both companies offer great long-term investment potential with attractive valuations.
Source: YAHOO